GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Longlife Hospital & Research Ltd (BOM:543520) » Definitions » YoY EBITDA Growth

Global Longlife Hospital & Research (BOM:543520) YoY EBITDA Growth : -218.29% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Global Longlife Hospital & Research YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Global Longlife Hospital & Research's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -218.29%.

Global Longlife Hospital & Research's EBITDA per Share for the six months ended in Mar. 2024 was ₹-2.83.

Global Longlife Hospital & Research YoY EBITDA Growth Historical Data

The historical data trend for Global Longlife Hospital & Research's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Longlife Hospital & Research YoY EBITDA Growth Chart

Global Longlife Hospital & Research Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EBITDA Growth
Get a 7-Day Free Trial -49.27 55.51 56.44 -47.42 -105.61

Global Longlife Hospital & Research Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only - -72.34 64.08 44.39 -218.29

Global Longlife Hospital & Research YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Global Longlife Hospital & Research's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (A: Mar. 2024 )
=(EBITDA per Share (A: Mar. 2024 )-EBITDA per Share (A: Mar. 2023 ))/ | EBITDA per Share (A: Mar. 2023 ) |
=(-0.235-4.187)/ | 4.187 |
=-105.61 %

Global Longlife Hospital & Research's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-2.826-2.389)/ | 2.389 |
=-218.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Longlife Hospital & Research YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Global Longlife Hospital & Research's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Longlife Hospital & Research (BOM:543520) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Longlife Hospital & Research Ltd (BOM:543520) » Definitions » YoY EBITDA Growth
Comparable Companies
BOM:516110 BOM:530897 NSE:SANGANI BOM:539428 BOM:523489 BOM:539378 BOM:534422 BOM:531043 NSE:AATMAJ BOM:543346 HCA SAU:4013 SZSE:300015 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS
Traded in Other Exchanges
N/A
Address
Pakwan Cross Road, Near Sindhubhavan Road, Near Water Tank, Opposite Auda Garden, Bodakdev, Ahmedabad, GJ, IND, 380054
Website
https://www.globalhospital.co.in
Global Longlife Hospital & Research Ltd provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services.

Global Longlife Hospital & Research (BOM:543520) Headlines

No Headlines